APA (7th ed.) Citation

A, G., V, S., MI, F., MÁ, N., A, A., MI, Q., . . . JC, F. (2026). The Role of Butyrate in People with Metabolic Dysfunction-Associated Steatotic Liver Disease and Related Metabolic Comorbidities: A Systematic Review. Current obesity reports, 15(1), . https://doi.org/10.1007/s13679-026-00694-8

Chicago Style (17th ed.) Citation

A, González-González, Soria-Utrilla V, Fontalba-Romero MI, Núñez-Sánchez MÁ, Adarve-Castro A, Queipo-Ortuño MI, Ramos-Molina B, Martínez-Montoro JI, and Fernández-García JC. "The Role of Butyrate in People with Metabolic Dysfunction-Associated Steatotic Liver Disease and Related Metabolic Comorbidities: A Systematic Review." Current Obesity Reports 15, no. 1 (2026). https://doi.org/10.1007/s13679-026-00694-8.

MLA (9th ed.) Citation

A, González-González, et al. "The Role of Butyrate in People with Metabolic Dysfunction-Associated Steatotic Liver Disease and Related Metabolic Comorbidities: A Systematic Review." Current Obesity Reports, vol. 15, no. 1, 2026, https://doi.org/10.1007/s13679-026-00694-8.